Concepedia

Carrianne Ludwig

CL

4

Publications

148

Citations

4

H-Index

2005

Active since

Affiliations

University of Colorado Denver(Current)

Washington University in St. Louis

AbbVie (United States)

Sidney Kimmel Comprehensive Cancer Center

Mayo Clinic Hospital

Carrianne Ludwig is an author at University of Colorado Denver specializing in lung cancer, health sciences, and cancer therapeutics.

Top concepts

Publications per year

2005–2021

4

Publications

4

A phase I/II study of rovalpituzumab tesirine in delta-like 3—expressing advanced solid tumors

Aaron S. Mansfield, David S. Hong, Christine L. Hann et al. · npj Precision Oncology · 2021 · 69 citations · Full text

A Phase 1 Study Evaluating Rovalpituzumab Tesirine in Frontline Treatment of Patients With Extensive-Stage SCLC

Christine L. Hann, Timothy F. Burns, Afshin Dowlati et al. · Journal of Thoracic Oncology · 2021 · 41 citations · Full text

O-082 A randomized phase III trial comparing ionafarnib/carboplatin/paclitaxel versus carboplatin/paclitaxel (CP) in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC)

George R. Blumenschein, Carrianne Ludwig, Glyn Thomas et al. · Lung Cancer · 2005 · 24 citations

, , +8

A phase I/II study of rovalpituzumab tesirine in delta-like 3-expressing, advanced solid tumors.

Aaron S. Mansfield, David S. Hong, Christine L. Hann et al. · Journal of Clinical Oncology · 2020 · 14 citations

Rows per page

1–4 of 4